Our data support a positive regulatory role for both P2Y1 and PKD1, particularly in obese (but nondiabetic) donors, suggesting a role for this pathway in compensatory upregulation of insulin secretion and that disruption of P2Y1‐PKD1 signaling may promote β cell dysfunction in type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.